The impact of EMA recommendations on the real-life use of Janus kinases inhibitors for rheumatoid arthritis: the Expanded Risk Score in RA as a tool to quantify the risk of cardiovascular events

OBJECTIVE: To evaluate in patients with rheumatoid arthritis (RA) the impact of EMA recommendations on the real-life prescription of JAK inhibitors (JAKis) and the use of the Expanded Risk Score in RA (ERS-RA) to quantify the risk of major adverse cardiac events (MACE). METHODS: We conducted a retro...

Descripción completa

Detalles Bibliográficos
Autores principales: Favalli, Ennio Giulio, Cincinelli, Gilberto, Germinario, Sabino, Di Taranto, Raffaele, Orsini, Francesco, Maioli, Gabriella, Biggioggero, Martina, Ferrito, Matteo, Caporali, Roberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500057/
https://www.ncbi.nlm.nih.gov/pubmed/37720218
http://dx.doi.org/10.3389/fimmu.2023.1225160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500057/
https://www.ncbi.nlm.nih.gov/pubmed/37720218
http://dx.doi.org/10.3389/fimmu.2023.1225160

Ejemplares similares